Aptamers: A New Technological Platform in Cancer Immunotherapy

Author： Pastor Fernando  

Publisher： MDPI

E-ISSN： 1424-8247|9|4|64-64

ISSN： 1424-8247

Source： Pharmaceuticals, Vol.9, Iss.4, 2016-10, pp. : 64-64

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Mechanisms and Αpplications of Ιnterleukins in Cancer Immunotherapy

By Anestakis Doxakis   Petanidis Savvas   Kalyvas Spyridon   Nday Christiane M.   Tsave Olga   Kioseoglou Efrosini   Salifoglou Athanasios  

International Journal of Molecular Sciences, Vol. 16, Iss. 1, 2015-01 ,pp. : 1691-1710

MDPI

Access to resources Recommend Favorite

Improved Aptamers for the Diagnosis and Potential Treatment of HER2-Positive Cancer

By Gijs Marlies   Penner Gregory   Blackler Garth B.   Impens Nathalie R.E.N.   Baatout Sarah   Luxen André   Aerts An M.  

Pharmaceuticals, Vol. 9, Iss. 2, 2016-05 ,pp. : 29-29

MDPI

Access to resources Recommend Favorite

The between Now and Then of Lung Cancer Chemotherapy and Immunotherapy

By Visconti Roberta   Morra Francesco   Guggino Gianluca   Celetti Angela  

International Journal of Molecular Sciences, Vol. 18, Iss. 7, 2017-06 ,pp. : 1374-1374

MDPI

Access to resources Recommend Favorite

TIM-3 as a Target for Cancer Immunotherapy and Mechanisms of Action

By Du Wenwen   Yang Min   Turner Abbey   Xu Chunling   Ferris Robert L.   Huang Jianan   Kane Lawrence P.   Lu Binfeng  

International Journal of Molecular Sciences, Vol. 18, Iss. 3, 2017-03 ,pp. : 645-645

MDPI

Access to resources Recommend Favorite

Cancer Immunology with a Focus on Understudied Cancers as Targets for Immunotherapy

By Young M. Rita I.  

International Journal of Molecular Sciences, Vol. 18, Iss. 1, 2017-01 ,pp. : 127-127

MDPI

Access to resources Recommend Favorite